Literature DB >> 17664180

Clinical presentation and outcome in a cohort of paediatric patients with membranous lupus nephritis.

Carl H Cramer1, Michelle Mills, Rudolph P Valentini, William E Smoyer, Hillary Haftel, Patrick D Brophy.   

Abstract

BACKGROUND: Membranous glomerulopathy accounts for 28% of the biopsy-proven systemic lupus erythematosus nephritis in paediatric patients at the time of first biopsy, yet minimal data are available regarding outcomes in this population.
METHODS: We present a retrospective analysis of 26 paediatric patients with World Health Organization class V lupus nephritis. Patients were subdivided based on renal biopsy findings into the following subclasses: 16 (63%) Va, 2 (9%) Vb, 7 (26%) Vc and 1 (4%) Vd. We evaluated outcomes of renal function and urine protein to creatinine ratio (UPr/UCr).
RESULTS: Mean follow-up time was 38.6 (+/-22) months. Eight patients at presentation had a glomerular filtration rate (GFR) <90 ml/min/1.73 m(2), six with Va and two with Vc. The initial presenting serum creatinine was predictive of renal function at last follow-up in class Va and Vb patients (P = 0.002). Twenty-one of the 26 patients had GFR > or = 90 ml/min/1.73 m(2) at last follow-up; the five patients with GFR <90 ml/min/1.73 m(2) were all lupus class Va. Cyclophosphamide (CTX) therapy did not demonstrate a significant improvement in outcome. The following parameters failed to predict GFR at last follow-up visit: blood pressure, C3, C4 and UPr/UCr.
CONCLUSIONS: The initial creatinine in patients with classes Va and Vb lupus nephritis predicted follow-up renal function. We found no correlation with outcome based on therapy with CTX and/or mycophenolate mofetil.

Entities:  

Mesh:

Year:  2007        PMID: 17664180     DOI: 10.1093/ndt/gfm491

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

1.  Clinical presentation and outcomes of childhood-onset membranous lupus nephritis.

Authors:  Maria Pereira; Eyal Muscal; Karen Eldin; M John Hicks; Anna Carmela P Sagcal-Gironella; Marietta DeGuzman; Scott E Wenderfer
Journal:  Pediatr Nephrol       Date:  2017-07-17       Impact factor: 3.714

Review 2.  Membranous lupus nephritis in Chinese children--a case series and review of the literature.

Authors:  Sik-Nin Wong; Winnie Kwai-Yu Chan; Joannie Hui; Stella Chim; Tsz-Leung Lee; Kwok-Piu Lee; Lettie Chuk-Kwan Leung; Niko Kei-Chiu Tse; So-Fun Yuen
Journal:  Pediatr Nephrol       Date:  2009-07-22       Impact factor: 3.714

3.  Presentation and outcome of paediatric membranous non-proliferative lupus nephritis.

Authors:  Boris Hugle; Earl D Silverman; Pascal N Tyrrell; Elizabeth A Harvey; Diane Hébert; Susanne M Benseler
Journal:  Pediatr Nephrol       Date:  2014-07-31       Impact factor: 3.714

Review 4.  Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma.

Authors:  Chi Chiu Mok
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

5.  Clinical characteristics of children with membranous lupus nephritis: the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.

Authors:  A Boneparth; S E Wenderfer; L Nandini Moorthy; S M Radhakrishna; A C P Sagcal-Gironella; E von Scheven
Journal:  Lupus       Date:  2016-08-20       Impact factor: 2.911

6.  Immunoadsorption: a new strategy to induce remission in membranous lupus nephritis.

Authors:  Tim Ulinski; Aurélie Davourie-Salandre; Isabelle Brocheriou; Bilal Aoun
Journal:  Case Rep Nephrol Urol       Date:  2014-03-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.